Role of garlic in dyslipidemia: an evidence based review
Keywords:
Garlic Dyslipidemia, Lipid lowering agent, Cardiovascular diseaseAbstract
Rapidly growing morbidity and mortality due to heart disease is a great concerned for scientist. Among the etiology of atherosclerosis, dyslipidemia is a major risk factor. Garlic has active ingredients of allium sativum used in high blood pressure management. Garlic has been used as a therapeutic agent for many illnesses such as hypertension, dyslipidemia and cardiovascular diseases. Evidence from various studies and clinical trials proved the efficacy of garlic to reduce lipid level.However, some contradictory results are also reported. This review was undertaken to assess the role of garlic therapy in dyslipidemia. Major databases including Google, PubMed, MEDLINE, and Cochrane library view were used for literature search. Clinical trials conducted on humans assessing role of garlic therapy in dyslipidemia and the possible mechanisms responsible for such therapeutic actions were assessed. Several trials and meta-analyses have suggested positive effect of garlic on total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL) and triglycerides (TG). This review on garlic therapy in dyslipidemia suggests that it reduces elevated cholesterol to a modest extent.
References
Lewington, S., Whitlock, G., Clarke, R., 2007. Prospective Studies Collaboration Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular death. Lancet., 370(9602), 1829-1839.
Lloyd-Jones, D., Adams, R., Carnethon, M., 2009. Heart disease and stroke statistics 2009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation., 119(3), 480-486.
Law, M.R., Wald, N.J.,Thompson, S.J., 1994. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease. British Med. J., 308(6925):367.
Celermajer, D.S., Chow, C.K., Marijon, E., Anstey, N.M., Woo, K.S., 2012. Cardiovascular Disease in the Developing World Prevalence’s, Patterns, and the Potential of Early Disease Detection. J. Am. Coll. Cardiol., 60(14), 1207-1216.
Frass, M., Strassl, R.P., Friehs, H., 2012. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J., 12(1), 45-56.
Ernst, E., 1986. Cardiovascular effects of garlic (Allium sativum): a review. Pharma therapeutica.5(2): 83-89.
Thomson M, Al-Qattan K K, Bordia T (2006). Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J. nutrit., 136(3), 800-802.
Steiner, M., Li, W., 2001. Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions. J. nutrit., 131(3), 980-984,.
Banerjee, S.K., Maulik, S.K., 2002. Effect of garlic on cardiovascular disorders: a review. Nutrit. j., 1(1), 4.
Rahman, K., Lowe, G.M., 2006. Garlic and cardiovascular disease: a critical review. J. nutrit., 136(3), 736-740.
Jani, A., Mehta, A., 2007. Pharmacology of Allium sativum in relation to Cytochrome P450 and possible drug interactions. Pharmacog. Rev., 1(2), 222.
Allison, G.L., Lowe, G.M., Rahman, K., 2006. Aged garlic extract and its constituents inhibit platelet aggregation through multiple mechanisms. J. nutrit., 136(3), 782-788.
Rahman, K., Billington, D., 2000. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J. nutrit., 130(11) 2662-2665.
Warshafsky, S., Kamer, R.S., Sivak, S.L., 1993. Effect of Garlic on Total Serum Cholesterol, A Meta-Analysis. Annal. inter. med., 119(7), 599-605.
Stevinson, C., Pittler, M.H., Ernst, E., 2000. Garlic for treating hypercholesterolemia meta-analysis of randomized clinical trials. Annal. inter. med., 133(6), 420-429.
Ackermann, R.T., Mulrow, C.D., Ramirez, G., 2001. Garlic shows promise for improving some cardiovascular risk factors. Arch. inter. med., 161(6), 813.
Qidwai, W., Ashfaq, T., 2013. Role of Garlic Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach.Evidence-Based Complementary and Alternat. Med., 2013, 1-9. Article ID 125649.
Khoo, Y.S.K., Aziz, Z., 2009. Garlic supplementation and serum cholesterol: a meta-analysis. J. clin. pharmacy therapeut., 34(2), 133-145.
Osamor, P.E., Owumi, B.E., 2010. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC complementary alternat. med., 10(1), 36.
Zhang, X.H., Lowe, D., Giles, P., 2001. A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners. Blood coagulat. fibrinolys., 12(1), 67-74.
Duda, G.,Suliburska, J., Pupek-Musialik, D., 2008. Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults. Pharmacolog. report., 60(2), 163.
Lau, B.H.S., 2006. Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J. nutrit., 136(3), 765-768.
Zeng, T., Zhang, C.L., Zhao, X.L., 2013. The roles of garlic on the lipid parameters: a systematic review of the literature. Crit. rev. food scie. nutrit., 53(3), 215-230.
Silagy, C., Nei, A., 1993. Garlic as a lipid lowering agent--a meta-analysis. J. Roy. Coll. Physic. London., 28(1), 39-45.
Zeng, T., Guo, F.F., Zhang, C.L., 2012. A meta-analysis of randomized, double blind, placebo controlled trials for the effects of garlic on serum lipid profiles. J. Sci. Food Agric., 92(9), 1892-1902.
Capraz, M., Dilek, M., Akpolat, T., 2007. Garlic, hypertension and patient education. Internat.J. cardiol., 121(1), 130-131.
Ashraf, R., Aami, K., Shaikh, A.R., 2005. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub. Med. Coll. Abbottabad., 17(3), 60-64.
Ried, K., Toben, C., Fakler, P., 2013. Effect of garlic on serum lipids: an updated meta-analysis. Nutrit. Rev., 71(5), 282-299.
Zeng, T., Zhang, C.L., Zhao, X.L., 2013.The roles of garlic on the lipid parameters: a systematic review of the literature. Crit. rev. food sci. nutrit., 53(3), 215-230.
Kojuri, J., Vosoughi, A.R., Akrami, M., 2007. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis., 6(5), 1476-512.
Nies, L.K., Cymbala, A.A., Kasten, S.L., 2006. Complementary and alternative therapies for the management of dyslipidemia. Annal. pharmacotherapy., 40(11), 1984-1992.
Steiner, M., Khan, A.H., Holbert, D., 1996. A double-blind crossover study in moderately hypercholesterolemia men that compared the effect of aged garlic extract and placebo administration on blood lipids. Amer. j. clin. nutrit., 64(6), 866-870.
Isaacsohn, J.L., Moser, M., Stein, E.A., 1998. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch. inter. med., 158(11), 1189.
Sobenin, I.A., Andrianova, I.V., Demidova, O.N., 2008. Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study. J. Atheroscler Thromb., 15(6), 334-338.
Gardner, C.D., Lawson, L.D., Block, E., 2007. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch. Inter. Med., 167(4), 346.
Reinhart, K.M., Talati, R.,White, C.M., 2009. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutrit. res. rev., 22(1), 39.
Superko, H.R., Ronald, K.M., 2000.Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J. Amer. Coll. Cardiol., vol. 35, no.2, pp.321-326
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 F. Jahan, K. Nanji, W. Qidwai
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
